Gain or Amplification of Chromosome 1q Mediate Multiple Myeloma Resistant to Xpo-1 Inhibitor Selinexor Via Transcription Factor ETV3

被引：0
|
作者：
Gu, Huiyao [1 ]
Zhong, Yi [1 ]
Zhang, Enfan [2 ]
Cao, Liqin [3 ]
Cai, Zhen [4 ]
He, Jingsong [5 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr,Dept Hematol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China
[5] Zhejiang Univ, Affiliated Hosp 1, Dept Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
ETV3; multiple myeloma; Gain or amplification of chromosome 1q; selinexor;
D O I：
10.1182/blood-2023-184720
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 39 条
  • [1] Transcriptional features of multiple myeloma patients with chromosome 1q gain
    S Fabris
    D Ronchetti
    L Agnelli
    L Baldini
    F Morabito
    S Bicciato
    D Basso
    K Todoerti
    L Lombardi
    G Lambertenghi-Deliliers
    A Neri
    Leukemia, 2007, 21 : 1113 - 1116
  • [2] Transcriptional features of multiple myeloma patients with chromosome 1q gain
    Fabris, S.
    Ronchetti, D.
    Agnelli, L.
    Baldini, L.
    Morabito, F.
    Bicciato, S.
    Basso, D.
    Todoerti, K.
    Lombardi, L.
    Lambertenghi-Deliliers, G.
    Neri, A.
    LEUKEMIA, 2007, 21 (05) : 1113 - 1116
  • [3] Transcriptional features of multiple myeloma patients with chromosome 1Q gain
    Fabris, S.
    Ronchetti, D.
    Agnelli, L.
    Baldini, L.
    Morabito, F.
    Bicciato, S.
    Basso, D.
    Todoerti, K.
    Lombardi, L.
    Lambertenghi-Deliliers, G.
    Neri, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 362 - 362
  • [4] Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy
    Hu, Xiao
    Wu, Cherng-Horng
    Cowan, Janet M.
    Comenzo, Raymond L.
    Varga, Cindy
    ANNALS OF HEMATOLOGY, 2022, 101 (02) : 369 - 378
  • [5] Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy
    Xiao Hu
    Cherng-Horng Wu
    Janet M. Cowan
    Raymond L. Comenzo
    Cindy Varga
    Annals of Hematology, 2022, 101 : 369 - 378
  • [6] Gain of chromosome arm 1q in patients in relapse and progression of multiple myeloma
    Balcarkova, Jana
    Urbankova, Helena
    Scudla, Vlastimil
    Holzerova, Milena
    Bacovsky, Jaroslav
    Indrak, Karel
    Jarosova, Marie
    CANCER GENETICS AND CYTOGENETICS, 2009, 192 (02) : 68 - 72
  • [7] Multiple myeloma with amplification of chromosome 1q is highly sensitive to MCL-1 targeting
    Slomp, Anne
    Moesbergen, Laura
    Gong, Jia-nan
    Cuenca, Marta
    Borne, Peter von dem
    Sonneveld, Pieter
    Huang, David
    Minnema, Monique
    Peperzak, Victor
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E49 - E50
  • [8] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
    Hanamura, Ichiro
    CANCERS, 2021, 13 (02) : 1 - 16
  • [9] Outcomes of Patients with Multiple Myeloma Harboring Gain/Amplification 1q in the Era of Modern Therapy
    Hu, Xiao
    Wu, Cherng-Horng
    Cowan, Janet
    Comenzo, Raymond L.
    Varga, Cindy
    BLOOD, 2020, 136
  • [10] Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature
    Barbieri, Emiliano
    Martino, Enrica Antonia
    Rivolti, Elena
    Quaresima, Micol
    Vigna, Ernesto
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (05) : 365 - 381
1234